Arbutus Biopharma

$1.67
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (1.83%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ABUS and other stocks, options, ETFs, and crypto commission-free!

About ABUS

Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada.

Employees
80
Headquarters
Burnaby, British Columbia
Founded
2005
Market Cap
94.94M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
174.80K
High Today
$1.72
Low Today
$1.61
Open Price
$1.66
Volume
125.22K
52 Week High
$10.15
52 Week Low
$1.29

Collections

ABUS Earnings

-$0.47
-$0.41
-$0.36
-$0.30
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 6, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.